Kessler Topaz Meltzer & Check, LLP Reminds PACS Investors of January 13, 2025 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm

Core Viewpoint - A securities class action lawsuit has been filed against PACS Group, Inc. for allegedly making materially false and misleading statements regarding its business operations and financial performance during the Class Period from April 11, 2024, to November 5, 2024 [1]. Group 1: Allegations Against PACS Group, Inc. - The lawsuit claims that PACS engaged in a scheme to submit false Medicare claims, which accounted for more than 100% of its operating and net income from 2020 to 2023 [3]. - It is alleged that PACS billed for thousands of unnecessary respiratory and sensory integration therapies to Medicare [3]. - The company is accused of falsifying documentation related to licensure and staffing, leading to misleading positive statements about its business and prospects [3]. Group 2: Legal Process and Investor Information - Investors who purchased PACS stock during the Class Period can seek to be appointed as lead plaintiffs by January 13, 2025, or remain absent class members [4]. - The lead plaintiff will represent the interests of all class members and select counsel to direct the litigation [4]. - Kessler Topaz Meltzer & Check, LLP encourages affected investors to contact them for more information regarding the lawsuit [5].